Civic Data
FDA RecallsUSDA RecallsAbout

FDA Recalls

  • Food recalls
  • Drug recalls
  • Device recalls

USDA Recalls

  • All USDA recalls
  • Poultry recalls
  • Meat recalls
  • Egg recalls

About

  • About us
  • FDA guides
  • USDA guides
  • Data sources
  • Privacy policy

Data

  • OpenFDA API
  • USDA FSIS

© 2026Civic Data · Data sourced from OpenFDA and USDA FSIS · Not affiliated with the U.S. Food and Drug Administration or the U.S. Department of Agriculture · Always verify against official sources before acting

  1. FDA Recalls
  2. ›Drug Recalls

FDA Drug Recalls

Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.

Classification
AllClass IClass IIClass III
Status
AllOngoingCompletedTerminated
Date
All timePast 30 daysPast 12 months

Showing 16361–16380 of 17,860 recalls

Class IIOngoing

Guanabenz 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Sermorelin/GHRP 3 mg/3 mg vial, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Praziquantel 56.8mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Trimix, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Aminocaproic Acid 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Idoxuridine 0.1% Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Enrofloxacin 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Gentamicin Sulfate 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Vitamin B12 (3000 mcg/ml & 5000 mcg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Testosterone Cypionate (100 mg/ml & 200 mg/ml) Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

ITPP 50 mg/ml DMG 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Gaba 50 mg/Mag Sulfate 50 mg/Taurine/Theanine 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Xylazine 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Altrenogest 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Cre-O-Pan Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Lipotoxin Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Progesterone 100 mg/ml in Olive Oil Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Metoclopramide 5 mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Calcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
Class IIOngoing

Phenylephrine 1 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

May 29, 2013 · DrugView details →
← PreviousPage 819 of 893Next →